The focus of this review article is to explore EGCG and GS as the potential treatments through varying methods (AChE inhibitor, diet, fecal microbiota transplantation, neural stem cell therapy, and nanomaterials) to target the dysbiosis in the gut microbiome, which has a considerable influence on the course of AD. Here, ACHE is linked to Alzheimer disease.